Wyeth Ayerst's pneumococcal vaccine `Prevenar' is to be reimbursed for at-risk infants in France, announce health insurance authorities in that country, reports Scrip.

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.396, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

By Duggan Sean T.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1973-1986

Adis International

Access to resources Recommend Favorite

Pneumococcal conjugate vaccine immunogenic in infants

By  

Inpharma, Vol. 1, Iss. 1472, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

South Africa plans to phase in routine vaccination with pneumococcal 7-valent CRM197 vaccine conjugate [Prevenar]

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 563, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]†: Profile Report

By Duggan Sean T.  

Pediatric Drugs, Vol. 14, Iss. 1, 2012-02 ,pp. : 67-69

Adis International

Access to resources Recommend Favorite

Pneumococcal conjugate vaccine: benefits in healthy infants

By  

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite